Ideas to action: independent research for global prosperity
Research
Innovative, independent, peer-reviewed. Explore the latest economic research and policy proposals from CGD’s global development experts.
POLICY PAPERS
May 09, 2024
CGD NOTES
May 07, 2024
WORKING PAPERS
April 23, 2024
WORKING PAPERS
May 01, 2024
All Research
Filters:
Experts
Facet Toggle
Topics
Facet Toggle
Publication Type
Facet Toggle
Time Frame
Facet Toggle
Research
CGD NOTES
November 07, 2022
The assignment is clear. During this year’s Annual Meetings of the IMF and World Bank, shareholders instructed the World Bank to develop a work program for its own evolution (“to identify gaps in the Bank’s current institutional and operational framework…”) by the end of the year. Secretary Yellen l...
CGD NOTES
September 29, 2022
This note provides actionable advice on measurement for project teams working on digital government-to-person projects, as well as practitioners and researchers working on cash transfer payments and financial inclusion more broadly. It provides short measures focused on key outcomes related to women...
CGD NOTES
June 28, 2022
Since the onset of the COVID-19 pandemic and resulting global recession, researchers have documented the economic impacts of the crisis, including in the form of individuals’ lost employment and income and increased poverty and food insecurity within households. To respond to these impacts, about 20...
CGD NOTES
May 19, 2022
The stakes are high for the African Development Fund (AfDF) as it kicks off its replenishment fundraising exercise this spring. Countries in sub-Saharan Africa (SSA) are still grappling with the health and economic fallout of the COVID-19 crisis, with over 30 million of their citizens pushed into po...
BRIEFS
April 28, 2022
COVID-19 has disrupted health systems across the globe. Nigeria reported its first COVID-19 case in February 2020, and, since then, the government has rolled out four vaccines to help control the pandemic—Moderna, Oxford-Astra Zeneca (AZ), Johnson & Johnson (J&J) and Pfizer-BioNTech.